Rationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virus
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virus
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 10, Issue 3, Pages 607-614
Publisher
Informa UK Limited
Online
2013-12-07
DOI
10.4161/hv.27426
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of RSV-related hospitalization and non-compliance with Palivizumab among commercially insured infants: a retrospective claims analysis
- (2013) Dan L Stewart et al. BMC INFECTIOUS DISEASES
- Respiratory Syncytial Virus-Associated Hospitalizations Among Children Less Than 24 Months of Age
- (2013) C. B. Hall et al. PEDIATRICS
- Three monthly doses of palivizumab are not adequate for 5-month protection: A population pharmacokinetic analysis
- (2013) William V. La Via et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Population Pharmacokinetics of Palivizumab, a Humanized Anti-Respiratory Syncytial Virus Monoclonal Antibody, in Adults and Children
- (2012) Gabriel J. Robbie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Respiratory Function in Healthy Late Preterm Infants Delivered at 33-36 Weeks of Gestation
- (2012) Cindy McEvoy et al. JOURNAL OF PEDIATRICS
- The evolution of risk factors for respiratory syncytial virus-related hospitalisation in infants born at 32–35 weeks’ gestational age: time-based analysis using data from the FLIP-2 study
- (2012) Xavier Carbonell et al. JOURNAL OF PERINATAL MEDICINE
- Preterm neonates show marked leukopenia and lymphopenia that are associated with increased regulatory T-cell values and diminished IL-7
- (2012) Rafael Correa-Rocha et al. PEDIATRIC RESEARCH
- Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study
- (2011) Jon P. Fryzek et al. ADVANCES IN THERAPY
- Animal models of human respiratory syncytial virus disease
- (2011) Reinout A. Bem et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997–2006
- (2011) Lauren J. Stockman et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Respiratory Morbidity and Lung Function in Preterm Infants of 32 to 36 Weeks' Gestational Age
- (2010) A. A. Colin et al. PEDIATRICS
- Modified Recommendations for Use of Palivizumab for Prevention of Respiratory Syncytial Virus Infections
- (2009) PEDIATRICS
- Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry
- (2008) M Frogel et al. Journal of Perinatology
- FLIP-2 Study
- (2008) José Figueras-Aloy et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search